tirzepatide raise blood pressure Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats GLP-1 drugs tied to elevated

Unfortunately, there are a number of additional side effects that the manufacturer failed to notify users of

STEP Trial Evidence 15% Average Weight Reduction The semaglutide STEP trial program produced some of the most impressive weight loss outcomes ever documented in a pharmaceutical trial average 14.9% body weight reduction at 68 weeks

Some individuals report clothing fitting differently or slight visual changes in mirror assessment

Constipation may also predispose bacteria to reach excessive populations, particularly Lactobacillus species that can execute tyrosine decarboxylation, L-DOPA by converting it into dopamine in the gut hence limiting its release into the bloodstream and causing motor fluctuations (Menozzi and Schapira, 2024)